MedTrace Logo

Effects of Beetroot Juice Intake on Performance and Physiological Parameters

NCT06073275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-10-10

No results posted yet for this study

Summary

This study was a randomized, double-blind, crossover design for 3 weeks. In the first week, a researcher explained all the experimental procedures to the participants. In the following two weeks, the participants attended the Exercise Physiology laboratory to be assessed in 2 rowing ergometer sessions, separated from each other by a washout period of 7 days, under the same environmental conditions.

In both strictly identical sessions, the participants randomly ingested beetroot juice (BRJ) or placebo (PL) 3 hours before the start of the tests.

Conditions

  • Pulmonary Function
  • Nutrition, Healthy

Interventions

DIETARY_SUPPLEMENT

Beetroot juice ingestion

Beetroot juice ingestion was randomly administered 3 h before the start of the test to the participants in two assessment sessions with a one-week washout between both sessions.

DIETARY_SUPPLEMENT

Placebo ingestion

Placebo ingestion was randomly administered 3 h before the start of the test to the participants in two assessment sessions with a one-week washout between both sessions.

Sponsors & Collaborators

  • Campus docent Sant Joan de Déu-Universitat de Barcelona

    lead OTHER

Principal Investigators

  • Manuel V Garnacho-Castaño, PhD · Campus docent Sant Joan de Déu-Universitat de Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-01-31
Completion
2019-02-26

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06073275 on ClinicalTrials.gov